Loading clinical trials...

COMPLETED

Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Delay to Diagnosis and Management in Digestive Cancerology by the General Practitioner Within the City-hospital Network in the Context of Confinement Related to the Covid-19 Pandemic

NCT06118125•University of Bordeaux

View on ClinicalTrials.gov

Summary

Objective: the pre-hospital management of cancers is little known in General Medicine. The first lockdown related to the COVID-19 pandemic led to the closure of health facilities. Investigators were interested in the diagnosis and care pathway of digestive cancers in post-confinement in General Medicine in Nouvelle-Aquitaine.

Detailed Description

Method: patient records discussed in Digestive Oncology CPR of Bordeaux University Hospital for the first time from June 1 to August 31, 2020 and over the same period in 2019 were included. A questionnaire on the dates of the first symptoms, first consultation with the general practitioner, imaging examination and access to the specialist was sent to the general practitioner. The primary outcome was time from onset to date of first MDT.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•residing in New Aquitaine and
•whose general practitioner practiced in New Aquitaine
•malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas.
•to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.

Exclusion Criteria

•Patients under 18 years of age,
•who had already had a MDT for this cancer,
•whose date of first MDT was outside the inclusion dates,
•whose new cancer was a digestive metastasis of a primary of another location,
•who did not have French health insurance

Locations (1)

Blanc-Bisson Christele

Bordeaux, France

Key Dates

Start Date

June 1, 2019

Primary Completion Date

September 1, 2022

Completion Date

September 1, 2022

Last Updated

November 7, 2023

Enrollment

376

ACTUAL participants

Conditions

Neoplasms, ColorectalGeneral PractitionerPandemic, COVID-19Neoplasm, LiverNeoplasms PancreaticDiagnosisAdvanced Cancer

Prioritising Patient Medication Review: Hospitals Reaching Out

NCT06451692

Medication ReviewPolypharmacy+3 more

View study

NOT_YET_RECRUITING

Referral of Patients With Biological Abnormalities to an Emergency Department

NCT07405996

Biological AbnormalityEmergency Department Visit+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 7, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Inclusion Criteria

Exclusion Criteria

Prioritising Patient Medication Review: Hospitals Reaching Out

Referral of Patients With Biological Abnormalities to an Emergency Department

Socioeconomic Behavior Changes During the Pandemic

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Face Mask Habits and COVID-19 Among University Students in Cairo

A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway